Research output per year
Research output per year
Personal profile
Personal webpage
Linkedin http://nl.linkedin.com/pub/richard-van-wijk/15/462/a64/sv
Researchgate http://www.researchgate.net/profile/Richard_Van_Wijk2
Biography
Richard van Wijk did his PhD in 2004 in UMC Utrecht on molecular mechanisms of disease in hereditary red blood cell enzymopathies. Currently he holds a position of Associate Professor at the Department Central Diagnostic Laboratory of the UMC Utrecht. He combines diagnostics, consultancy, and (translational) research activities on rare hereditary disorders of the red blood cell, affecting its production, function, or survival. Under his supervision the Central Diagnostic Laboratory has established itself as a National and International Center of Expertise for diagnosis and research on rare red blood cell disorders. Novel advanced and state-of-the art laboratory methods and the concept of ‘personalized diagnostics’ are applied to diagnosing and investigating patients with such disorders. Because of their rarity, the pathophysiology of many of these disorders is poorly understood. The key element of his research therefore is to gain a better understanding of pathophysiology and genotype-to-phenotype correlations, and the identification of novel (modifier) genes.
External positions
Scientific Advisory Board - Advies diagnostiek zeldzame anemie - Rare Anemias International (RAIN)
1 Jun 2022 → 31 Dec 3999
Member of VHL - Regular meetings (1/4 months) - Dutch Society for Hematological Laboratory Investigation
1 Jan 2021 → 31 Dec 3999
Member of the Scientific Advisory Board on PKD of the RADEEP - Occasional meetings - Rare Aneamies Disorders European Epidemiological Platform
1 Jan 2019 → 31 Dec 3999
Consultancy en scientific advisory boards - Research nieuwe therapien zeldzame rode bloedcelstoornissen - Agios Pharmaceuticals
16 Aug 2017 → 31 Dec 3999
Consultancy en scientific advisory boards - Ontwikkelen nieuwe (diagnostische) laboratoriumtechnieken - RR Mechatronics
8 Feb 2017 → 31 Dec 3999
Member of the working group 'Non-oncological Hematology' of th NVvH - occasional meetings - Dutch Hematology Association (NVvH)
1 Jan 2013 → 31 Dec 3999
Member - Occasional meetings - European Hematology Association (EHA)
1 Jan 2013 → 31 Dec 3999
Member - Occasional meetings - Dutch Hematology Association (NVvH)
1 Jan 2013 → 31 Dec 3999
Member of EHA scientific Working Group on Red Cells and Iron - Occasional meetings - European Hematology Association (EHA)
1 Jan 2013 → 31 Dec 3999
abstract reviewer - reviewing of abstracts - European Hematology Association (EHA)
1 Jan 2013 → 31 Dec 3999
Reviewer for peer reviewed Journals - Reviewing papers - Papers for various Journals
1 Jan 2013 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Perspective on the Added Value of Red Blood Cells during Cardiac Hypothermic Oxygenated Perfusion
Vervoorn, M. T., Ballan, E. M., Kaffka Genaamd Dengler, S. E., Meijborg, V. M. F., de Jager, S. C. A., Van Wijk, R. & van der Kaaij, N. P., Feb 2025, In: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 44, 2, p. 285-288 4 p.Research output: Contribution to journal › Editorial › Academic › peer-review
-
Iron Deficiency in HbSC Disease Treated With Repetitive Phlebotomy Is Associated With Fewer Sickle Cell Disease-Related Complications
Traets, M. J. M., Kidane Gembremeskel, A. S., Eijkelenboom-Bos, J., van Oirschot, B. A., van der Veen, S., Russcher, H., van Solinge, W. W., Lauw, M. N., Nur, E., Biemond, B. J., Cnossen, M. H., Rijneveld, A. W., van Wijk, R., van Beers, E. J. & Rab, M. A. E., Nov 2025, In: American journal of hematology. 100, 11, p. 2123-2127 5 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open AccessFile -
Oxidantscan: A novel biomarker to assess red blood cell susceptibility to oxidative stress in sickle cell disease
Hernández, C. A., Traets, M. J. M., van Solinge, W. W., Rijneveld, A. W., Kaestner, L., John, T., Nur, E., Biemond, B. J., Kuypers, F. A., van Beers, E. J., Rab, M. A. E. & van Wijk, R., Mar 2026, In: Blood Cells, Molecules, & Diseases. 117, 9 p., 102967.Research output: Contribution to journal › Article › Academic › peer-review
-
Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease
Traets, M. J. M., Bos, J. F., van der Veen, S., van Pelt, L., van Dijk, M. J., van Oirschot, B. A., de Wilde, J. R. A., Jans, J. J., van Solinge, W. W., Schols, S. E. M., Lauw, M. N., Cnossen, M. H., Nur, E., Biemond, B. J., Rijneveld, A. W., van Beers, E. J., van Wijk, R. & Rab, M. A. E., May 2025, In: American journal of hematology. 100, 5, p. 785-796 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Rare Case of Homozygosity for CYB5R3 Variant c.235C > T p.(Arg79Trp) Causing Type II Methemoglobinemia
Bendtsen, S. K., Wijk, R. V., Petersen, J. B., Jensen, P., Helby, J. & Glenthøj, A., May 2025, In: Hemoglobin. 49, 3, p. 218-221 4 p.Research output: Contribution to journal › Article › Academic › peer-review